HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmela De Marco Selected Research

Carcinoma (Carcinomatosis)

5/2016Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
1/2016AKT1E¹⁷K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer.
1/2013Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma.
6/2007Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmela De Marco Research Topics

Disease

12Neoplasms (Cancer)
10/2022 - 06/2007
6Lung Neoplasms (Lung Cancer)
01/2022 - 01/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2017 - 01/2012
4Carcinoma (Carcinomatosis)
05/2016 - 06/2007
4Thyroid Neoplasms (Thyroid Cancer)
06/2010 - 03/2005
3Melanoma (Melanoma, Malignant)
02/2023 - 12/2011
2Hyperplasia
01/2019 - 01/2016
1COVID-19
10/2022
1Infections
01/2022
1Inflammation (Inflammations)
01/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Neuroinflammatory Diseases
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
03/2021
1Ovarian Epithelial Carcinoma
05/2016
1Tics (Tic)
12/2015
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
03/2012
1Adenocarcinoma
03/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2008
1Adenoma (Adenomas)
06/2007
1Breast Neoplasms (Breast Cancer)
08/2004

Drug/Important Bio-Agent (IBA)

3Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2012 - 08/2004
3Messenger RNA (mRNA)IBA
03/2012 - 06/2010
2MicroRNAs (MicroRNA)IBA
01/2022 - 03/2017
2Small Interfering RNA (siRNA)IBA
03/2021 - 12/2015
2Protein Kinases (Protein Kinase)IBA
01/2017 - 03/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 03/2012
2Cyclin-Dependent Kinase Inhibitor p27IBA
03/2012 - 06/2007
2Phosphotransferases (Kinase)IBA
01/2012 - 11/2007
2RNA (Ribonucleic Acid)IBA
01/2012 - 12/2011
2Proteins (Proteins, Gene)FDA Link
12/2011 - 11/2007
1Immune Checkpoint InhibitorsIBA
02/2023
1Monoclonal AntibodiesIBA
10/2022
1Antiviral Agents (Antivirals)IBA
10/2022
1Cyclin D1IBA
05/2022
1Volatile Fatty AcidsIBA
01/2022
1SuspensionsIBA
01/2022
1CytokinesIBA
01/2022
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2022
1Proteasome InhibitorsIBA
01/2019
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019
13- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
01/2019
1Bortezomib (Velcade)FDA Link
01/2019
1Oncogene Proteins (Oncogene Protein)IBA
01/2017
1PlatinumIBA
05/2016
1Aurora Kinase AIBA
05/2016
1Hyaluronic Acid (Hyaluronan)IBA
05/2016
1perfluoropolyetherIBA
05/2016
1Urethane (Ethyl Carbamate)IBA
01/2016
1CarcinogensIBA
01/2016
1NF-kappa B (NF-kB)IBA
12/2015
1Interleukin-6 (Interleukin 6)IBA
12/2015
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
12/2015
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2013
1Protein Tyrosine PhosphatasesIBA
03/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2012
1PhosphotyrosineIBA
03/2012
1Tyrosine (L-Tyrosine)FDA Link
03/2012
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
03/2012
1ErbB Receptors (EGF Receptor)IBA
03/2012
1Transcription Factors (Transcription Factor)IBA
01/2012
1ApoferritinsIBA
12/2011
1Ferritins (Ferritin)IBA
12/2011
1ProteomeIBA
12/2011
1IronIBA
12/2011
1NucleotidesIBA
03/2008
1N 30IBA
11/2007
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2007
1Antisense OligonucleotidesIBA
11/2007
1RacivirIBA
06/2007
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
06/2007
1Phospho-Specific AntibodiesIBA
03/2005
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
08/2004

Therapy/Procedure

4Therapeutics
02/2023 - 05/2016
2Drug Therapy (Chemotherapy)
01/2021 - 05/2016
1Secondary Prevention
10/2022
1Home Nursing (Nursing, Home)
01/2022